Literature DB >> 32425408

The Characteristics of AIHA Patients Benefited from Glucocorticoid Treatment.

Shijun Li1, Yuan Li2.   

Abstract

Entities:  

Year:  2019        PMID： 32425408      PMCID： PMC7229060          DOI： 10.1007/s12288-019-01224-4

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  5 in total

1.  Drug therapy of autoimmune hemolytic anemia.

Authors:  S Murphy; A F LoBuglio
Journal:  Semin Hematol       Date:  1976-10       Impact factor: 3.851

2.  Prognosis of autoimmune hemolytic anemia in critically ill patients.

Authors:  Antoine Lafarge; R Bertinchamp; C Pichereau; S Valade; A Chermak; I Theodose; E Canet; V Lemiale; B Schlemmer; L Galicier; E Azoulay; E Mariotte
Journal:  Ann Hematol       Date:  2018-12-10       Impact factor: 3.673

Review 3.  How I treat autoimmune hemolytic anemia.

Authors:  Ronald S Go; Jeffrey L Winters; Neil E Kay
Journal:  Blood       Date:  2017-03-30       Impact factor: 22.113

4.  The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes.

Authors:  M Guppy; E Greiner; K Brand
Journal:  Eur J Biochem       Date:  1993-02-15

Review 5.  Immune Hemolysis: Diagnosis and Treatment Recommendations.

Authors:  Wilma Barcellini
Journal:  Semin Hematol       Date:  2015-05-19       Impact factor: 3.851
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.